Cargando…

Long-Term Toxicity of (213)Bi-Labelled BSA in Mice

BACKGROUND: Short-term toxicological evaluations of alpha-radioimmunotherapy have been reported in preclinical assays, particularly using bismuth-213 ((213)Bi). Toxicity is greatly influenced not only by the pharmacokinetics and binding specificity of the vector but also by non-specific irradiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorso, Laëtitia, Bigot-Corbel, Edith, Abadie, Jérôme, Diab, Maya, Gouard, Sébastien, Bruchertseifer, Frank, Morgenstern, Alfred, Maurel, Catherine, Chérel, Michel, Davodeau, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794211/
https://www.ncbi.nlm.nih.gov/pubmed/26982495
http://dx.doi.org/10.1371/journal.pone.0151330
_version_ 1782421454880505856
author Dorso, Laëtitia
Bigot-Corbel, Edith
Abadie, Jérôme
Diab, Maya
Gouard, Sébastien
Bruchertseifer, Frank
Morgenstern, Alfred
Maurel, Catherine
Chérel, Michel
Davodeau, François
author_facet Dorso, Laëtitia
Bigot-Corbel, Edith
Abadie, Jérôme
Diab, Maya
Gouard, Sébastien
Bruchertseifer, Frank
Morgenstern, Alfred
Maurel, Catherine
Chérel, Michel
Davodeau, François
author_sort Dorso, Laëtitia
collection PubMed
description BACKGROUND: Short-term toxicological evaluations of alpha-radioimmunotherapy have been reported in preclinical assays, particularly using bismuth-213 ((213)Bi). Toxicity is greatly influenced not only by the pharmacokinetics and binding specificity of the vector but also by non-specific irradiation due to the circulating radiopharmaceutical in the blood. To assess this, an acute and chronic toxicity study was carried out in mice injected with (213)Bi-labelled Bovine Serum Albumin ((213)Bi-BSA) as an example of a long-term circulating vector. METHOD: Biodistribution of (213)Bi-BSA and (125)I-BSA were compared in order to evaluate (213)Bi uptake by healthy organs. The doses to organs for injected (213)Bi-BSA were calculated. Groups of nude mice were injected with 3.7, 7.4 and 11.1 MBq of (213)Bi-BSA and monitored for 385 days. Plasma parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN) and creatinine, were measured and blood cell counts (white blood cells, platelets and red blood cells) were performed. Mouse organs were examined histologically at different time points. RESULTS: Haematological toxicity was transient and non-limiting for all evaluated injected activities. At the highest injected activity (11.1 MBq), mice died from liver and kidney failure (median survival of 189 days). This liver toxicity was identified by an increase in both ALT and AST and by histological examination. Mice injected with 7.4 MBq of (213)Bi-BSA (median survival of 324 days) had an increase in plasma BUN and creatinine due to impaired kidney function, confirmed by histological examination. Injection of 3.7 MBq of (213)Bi-BSA was safe, with no plasma enzyme modifications or histological abnormalities. CONCLUSION: Haematological toxicity was not limiting in this study. Liver failure was observed at the highest injected activity (11.1 MBq), consistent with liver damage observed in human clinical trials. Intermediate injected activity (7.4 MBq) should be used with caution because of the risk of long-term toxicity to kidneys.
format Online
Article
Text
id pubmed-4794211
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47942112016-03-23 Long-Term Toxicity of (213)Bi-Labelled BSA in Mice Dorso, Laëtitia Bigot-Corbel, Edith Abadie, Jérôme Diab, Maya Gouard, Sébastien Bruchertseifer, Frank Morgenstern, Alfred Maurel, Catherine Chérel, Michel Davodeau, François PLoS One Research Article BACKGROUND: Short-term toxicological evaluations of alpha-radioimmunotherapy have been reported in preclinical assays, particularly using bismuth-213 ((213)Bi). Toxicity is greatly influenced not only by the pharmacokinetics and binding specificity of the vector but also by non-specific irradiation due to the circulating radiopharmaceutical in the blood. To assess this, an acute and chronic toxicity study was carried out in mice injected with (213)Bi-labelled Bovine Serum Albumin ((213)Bi-BSA) as an example of a long-term circulating vector. METHOD: Biodistribution of (213)Bi-BSA and (125)I-BSA were compared in order to evaluate (213)Bi uptake by healthy organs. The doses to organs for injected (213)Bi-BSA were calculated. Groups of nude mice were injected with 3.7, 7.4 and 11.1 MBq of (213)Bi-BSA and monitored for 385 days. Plasma parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN) and creatinine, were measured and blood cell counts (white blood cells, platelets and red blood cells) were performed. Mouse organs were examined histologically at different time points. RESULTS: Haematological toxicity was transient and non-limiting for all evaluated injected activities. At the highest injected activity (11.1 MBq), mice died from liver and kidney failure (median survival of 189 days). This liver toxicity was identified by an increase in both ALT and AST and by histological examination. Mice injected with 7.4 MBq of (213)Bi-BSA (median survival of 324 days) had an increase in plasma BUN and creatinine due to impaired kidney function, confirmed by histological examination. Injection of 3.7 MBq of (213)Bi-BSA was safe, with no plasma enzyme modifications or histological abnormalities. CONCLUSION: Haematological toxicity was not limiting in this study. Liver failure was observed at the highest injected activity (11.1 MBq), consistent with liver damage observed in human clinical trials. Intermediate injected activity (7.4 MBq) should be used with caution because of the risk of long-term toxicity to kidneys. Public Library of Science 2016-03-16 /pmc/articles/PMC4794211/ /pubmed/26982495 http://dx.doi.org/10.1371/journal.pone.0151330 Text en © 2016 Dorso et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Dorso, Laëtitia
Bigot-Corbel, Edith
Abadie, Jérôme
Diab, Maya
Gouard, Sébastien
Bruchertseifer, Frank
Morgenstern, Alfred
Maurel, Catherine
Chérel, Michel
Davodeau, François
Long-Term Toxicity of (213)Bi-Labelled BSA in Mice
title Long-Term Toxicity of (213)Bi-Labelled BSA in Mice
title_full Long-Term Toxicity of (213)Bi-Labelled BSA in Mice
title_fullStr Long-Term Toxicity of (213)Bi-Labelled BSA in Mice
title_full_unstemmed Long-Term Toxicity of (213)Bi-Labelled BSA in Mice
title_short Long-Term Toxicity of (213)Bi-Labelled BSA in Mice
title_sort long-term toxicity of (213)bi-labelled bsa in mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794211/
https://www.ncbi.nlm.nih.gov/pubmed/26982495
http://dx.doi.org/10.1371/journal.pone.0151330
work_keys_str_mv AT dorsolaetitia longtermtoxicityof213bilabelledbsainmice
AT bigotcorbeledith longtermtoxicityof213bilabelledbsainmice
AT abadiejerome longtermtoxicityof213bilabelledbsainmice
AT diabmaya longtermtoxicityof213bilabelledbsainmice
AT gouardsebastien longtermtoxicityof213bilabelledbsainmice
AT bruchertseiferfrank longtermtoxicityof213bilabelledbsainmice
AT morgensternalfred longtermtoxicityof213bilabelledbsainmice
AT maurelcatherine longtermtoxicityof213bilabelledbsainmice
AT cherelmichel longtermtoxicityof213bilabelledbsainmice
AT davodeaufrancois longtermtoxicityof213bilabelledbsainmice